Company intelligence / Profile preview

CorEvitas

Waltham, Massachusetts, United Statescorevitas.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

CorEvitas is a leading provider of regulatory-grade, real-world evidence solutions focused on autoimmune and inflammatory diseases. It manages multiple longitudinal patient registries across more than 400 investigator sites and over 100,000 patients. Its proprietary data supports post-marketing safety monitoring, health economics research, precision medicine initiatives, and market access strategies for pharmaceutical and biotechnology companies.

Therapeutic areas: Women's HealthImmunology
Industry: Contract Research Organization

Partnerships

InovalonPharmaceutical/biotech industry partners

Beyond the preview

Go deeper on CorEvitas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CorEvitas.

Explore the full profile